Exact Sciences Applauds Passage of Medicare Coverage Pathway for Multi-Cancer Early Detection Tests.

Exact Sciences celebrates the passage of legislation establishing a Medicare coverage pathway for multi-cancer early detection tests. The legislation, backed by bipartisan support, aims to address the unmet need for cancer screening and expand access to emerging technology for millions of Medicare beneficiaries. Exact Sciences' Cancerguard test, designed to detect a wide range of cancers from a blood draw, has the potential to slash stage IV cancer diagnoses by 45% when added to standard-of-care screening.